Header
Header
Header
Mr ALOK AHIRWAR
M 23
fa lse
Health Summary
BLOOD COUNTS
THYROID PROFILE
Test Name Result
Please Watchout
LIPID PROFILE
DIABETES MONITORING
LIVER PROFILE
KIDNEY PROFILE
Test Name Result
ANEMIA STUDIES
RDW-SD 47
Everything looks good
RDW-CV 14.6
MCV 82.8
Please Watchout
MINERAL PROFILE
HEMATOLOGY REPORT
Fit India Full Body Checkup
Complete Blood Count (CBC)
RBC PARAMETERS
Hemoglobin 15.8 g/dL 13.0 - 17.0
Method : colorimetric
RBC Count 5.6 10^6/µl 4.5 - 5.5
Method : Electrical impedance
PCV 46.7 % 40 - 50
Method : Calculated
MCV 82.8 fl 83 - 101
Method : Calculated
MCH 27.9 pg 27 - 32
Method : Calculated
MCHC 33.7 g/dL 31.5 - 34.5
Method : Calculated
RDW (CV) 14.6 % 11.6 - 14.0
Method : Calculated
RDW-SD 47 fl 35.1 - 43.9
Method : Calculated
WBC PARAMETERS
TLC 6.1 10^3/µl 4 - 10
Method : Electrical impedance and microscopy
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils 63 % 40-80
Lymphocytes 30 % 20-40
Monocytes 5 % 2-10
Eosinophils 2 % 1-6
Basophils 0 % <2
Absolute leukocyte counts
Neutrophils. 3.84
Lymphocytes. 1.83
Monocytes. 0.31
Eosinophils. 0.12
Basophils. 0
PLATELET PARAMETERS
Platelet Count 229 10^3/µl 150 - 410
Method : Electrical impedance and microscopy
Mean Platelet Volume (MPV) 11.5 fL 9.3 - 12.1
Method : Calculated
PCT 0.3 % 0.17 - 0.32
Page 1 of 12
Patient Name : Mr ALOK AHIRWAR
DOB/Age/Gender : 23 Y/Male Bill Date : Jul 05, 2023, 01:29 PM
Patient ID / UHID : 4635424/RCL1934653 Sample Collected : Jul 06, 2023, 09:22 AM
Referred By : Dr. Sample Received : Jul 06, 2023, 11:12 AM
Sample Type : Whole blood EDTA Report Date : Jul 06, 2023, 12:20 PM
Barcode No : HT765503 Report Status : Final Report
Interpretation:
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections, leukemias, clotting
disorders and many other medical conditions.
Page 2 of 12
Patient Name : Mr ALOK AHIRWAR
DOB/Age/Gender : 23 Y/Male Bill Date : Jul 05, 2023, 01:29 PM
Patient ID / UHID : 4635424/RCL1934653 Sample Collected : Jul 06, 2023, 09:22 AM
Referred By : Dr. Sample Received : Jul 06, 2023, 11:12 AM
Sample Type : Whole blood EDTA Report Date : Jul 06, 2023, 02:30 PM
Barcode No : HT765503 Report Status : Final Report
HEMATOLOGY REPORT
Fit India Full Body Checkup
Erythrocyte Sedimentation Rate (ESR)
ESR - Erythrocyte Sedimentation Rate 10 mm/hr 0 - 10
Method : MODIFIED WESTERGREN
Interpretation:
ESR is also known as Erythrocyte Sedimentation Rate. An ESR test is used to assess inflammation in the body. Many conditions can cause an
abnormal ESR, so an ESR test is typically used with other tests to diagnose and monitor different diseases. An elevated ESR may occur in
inflammatory conditions including infection, rheumatoid arthritis ,systemic vasculitis, anemia, multiple myeloma , etc. Low levels are typically
seen in congestive heart failure, polycythemia ,sickle cell anemia, hypo fibrinogenemia , etc.
Page 3 of 12
Patient Name : Mr ALOK AHIRWAR
DOB/Age/Gender : 23 Y/Male Bill Date : Jul 05, 2023, 01:29 PM
Patient ID / UHID : 4635424/RCL1934653 Sample Collected : Jul 06, 2023, 09:22 AM
Referred By : Dr. Sample Received : Jul 06, 2023, 11:12 AM
Sample Type : Whole blood EDTA Report Date : Jul 06, 2023, 06:14 PM
Barcode No : HT765503 Report Status : Final Report
HEMATOLOGY REPORT
Fit India Full Body Checkup
HbA1C (Glycosylated Haemoglobin)
GLYCOSYLATED HEMOGLOBIN (HbA1c) 5.6 % <5.7
Method : HPLC
ESTIMATED AVERAGE GLUCOSE 114.02 mg/dL
Interpretation:
Interpretation For HbA1c% As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5
Age > 19 years
Goal of therapy: < 7.0
Therapeutic goals for glycemic control
Age < 19 years
Goal of therapy: <7.5
Note:
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still
have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled.
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular
disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 %
may not be appropriate.
Comments :
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as
compared to blood and urinary glucose determinations ADA criteria for correlation between HbA1c & Mean plasma glucose levels.
HbA1c(%) Mean Plasma Glucose (mg/dL) HbA1c(%) Mean Plasma Glucose (mg/dL)
6 126 12 298
8 183 14 355
10 240 16 413
Page 4 of 12
Patient Name : Mr ALOK AHIRWAR
DOB/Age/Gender : 23 Y/Male Bill Date : Jul 05, 2023, 01:29 PM
Patient ID / UHID : 4635424/RCL1934653 Sample Collected : Jul 06, 2023, 09:22 AM
Referred By : Dr. Sample Received : Jul 06, 2023, 11:12 AM
Sample Type : FLUORIDE F Report Date : Jul 06, 2023, 11:55 AM
Barcode No : BT763225 Report Status : Final Report
BIOCHEMISTRY REPORT
Fit India Full Body Checkup
Glucose Fasting (BSF)
GLUCOSE FASTING 99.7 mg/dL 70 - 100
Method : Hexokinase
Interpretation:
Status Fasting plasma glucose in mg/dL
Normal <100
Impaired fasting glucose 100 - 125
Diabetes =>126
Comment :
Blood glucose determinations in commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels
(hyperglycemia) may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyper function as well as other disorders.
Decreased glucose levels (hypoglycemia) may result from excessive insulin therapy insulinoma, or various liver diseases.
Note
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL or a random / 2 hour plasma glucose value of > or = 200
mg/dL with symptoms of diabetes mellitus.
2.Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis.
Page 5 of 12
Patient Name : Mr ALOK AHIRWAR
DOB/Age/Gender : 23 Y/Male Bill Date : Jul 05, 2023, 01:29 PM
Patient ID / UHID : 4635424/RCL1934653 Sample Collected : Jul 06, 2023, 09:22 AM
Referred By : Dr. Sample Received : Jul 06, 2023, 11:12 AM
Sample Type : Serum Report Date : Jul 06, 2023, 12:28 PM
Barcode No : BT763226 Report Status : Final Report
BIOCHEMISTRY REPORT
Fit India Full Body Checkup
Liver Function Test (LFT)
BILIRUBIN TOTAL 0.5 mg/dL 0 - 1.2
Method : Colorimetric Diazo
BILIRUBIN DIRECT 0.2 mg/dL 0 - 0.20
BILIRUBIN INDIRECT 0.3 mg/dL 0.1 - 1.0
Method : Calculation (T Bil - D Bil)
SGOT/AST 50.7 U/L up to 40
Method : IFCC without P5P
SGPT/ALT 125 U/L up to 41
Method : IFCC without P5P
SGOT/SGPT Ratio 0.41 - -
ALKALINE PHOSPHATASE 110 U/L 40 - 129
Method : IFCC
TOTAL PROTEIN 7.7 g/dL 6.0 - 7.8
Method : Biuret
ALBUMIN 5.0 g/dL 3.5 - 5.2
Method : Colorimetric
GLOBULIN 2.7 g/dL 2.3 - 3.5
Method : Calculation (T.P - Albumin)
ALBUMIN : GLOBULIN RATIO 1.85 - 1.0 - 2.1
Method : Calculation (Albumin/Globulin)
GAMMA GLUTAMYL TRANSFERASE (GGT) 79.2 U/L 5 -40
Method : ENZYMATIC
Interpretation:
The liver filters and processes blood as it circulates through the body. It metabolizes nutrients, detoxifies harmful substances, makes blood clotting proteins, and
performs many other vital functions. The cells in the liver contain proteins called enzymes that drive these chemical reactions. When liver cells are damaged or
destroyed, the enzymes in the cells leak out into the blood, where they can be measured by blood tests Liver tests check the blood for two main liver enzymes.
Aspartate aminotransferase (AST),SGOT: The AST enzyme is also found in muscles and many other tissues besides the liver. Alanine aminotransferase (ALT),
SGPT: ALT is almost exclusively found in the liver. If ALT and AST are found together in elevated amounts in the blood, liver damage is most likely present.
Alkaline Phosphatase and GGT: Another of the liver's key functions is the production of bile, which helps digest fat. Bile flows through the liver in a system of
small tubes (ducts), and is eventually stored in the gallbladder, under the liver. When bile flow is slow or blocked, blood levels of certain liver enzymes rise:
Alkaline phosphatase Gamma-utamyl transpeptidase (GGT) Liver tests may check for any or all of these enzymes in the blood. Alkaline phosphatase is by far
the most commonly tested of the three. If alkaline phosphatase and GGT are elevated, a problem with bile flow is most likely present. Bile flow problems can be
due to a problem in the liver, the gallbladder, or the tubes connecting them. Proteins are important building blocks of all cells and tissues. Proteins are necessary for
your body's growth, development, and health. Blood contains two classes of protein, albumin and globulin. Albumin proteins keep fluid from leaking out of blood
vessels. Globulin proteins play an important role in your immune system. Low total protein may indicate: 1.bleeding 2.liver disorder 3.malnutrition
4.agammaglobulinemia High Protein levels 'Hyperproteinemia: May be seen in dehydration due to inadequate water intake or to excessive water loss (eg, severe
vomiting, diarrhea, Addison's disease and diabetic acidosis) or as a result of increased production of proteins Low albumin levels may be caused by: 1.A poor diet
(malnutrition). 2.Kidney disease. 3.Liver disease. High albumin levels may be caused by: Severe dehydration.
Page 6 of 12
Patient Name : Mr ALOK AHIRWAR
DOB/Age/Gender : 23 Y/Male Bill Date : Jul 05, 2023, 01:29 PM
Patient ID / UHID : 4635424/RCL1934653 Sample Collected : Jul 06, 2023, 09:22 AM
Referred By : Dr. Sample Received : Jul 06, 2023, 11:12 AM
Sample Type : Serum Report Date : Jul 06, 2023, 12:28 PM
Barcode No : BT763226 Report Status : Final Report
BIOCHEMISTRY REPORT
Fit India Full Body Checkup
Kidney Function Test (KFT)
BLOOD UREA 23.1 mg/dL 16.6 - 48.5
Method : Urease
CREATININE 0.9 mg/dL 0.70 - 1.20
Method : Jaffe
BUN 10.79 mg/dL 6 - 20
Method : Urease
BUN/CREATININE RATIO 11.99
UREA / CREATININE RATIO 25.67
URIC ACID 6.2 mg/dL 3.4 - 7.0
Method : Enzymatic colorimetric
CALCIUM Serum 9.5 mg/dL 8.6 - 10.0
Method : BAPTA
PHOSPHORUS 4.5 mg/dL 2.5 - 4.5
Method : Molybdate UV
SODIUM 139.5 mmol/L 136 - 145
Method : ISE-Indirect
POTASSIUM 3.9 mmol/L 3.5 - 5.1
Method : ISE-Indirect
CHLORIDE 100.6 mmol/L 98 - 107
Method : ISE-Indirect
Interpretation:
Kidney function tests is a collective term for a variety of individual tests and proceduresthat can be done toevaluate how well the kidneys are functioning. Many
conditions can affect the ability of the kidneys to carryout their vital functions. Somelead to a rapid (acute) decline in kidney functionothers lead to a gradual
(chronic) declineinfunction. Both result in a buildup of toxic waste subst done on urine samples, as well as on blood samples. A number of symptoms may
indicate a problem with your kidneys. These include : high blood pressure,blood in urine frequent urges to urinate,difficulty beginning urination,painful
urination,swelling in the hands and feet due to a buildup of fluids in the body. A single symptom may not mean something serious. However, when occurring
simultaneously, these symptoms suggest that your kidneys are not working properly. Kidney function tests can help determine the reason. Electrolytes
(sodium,potassium,and chloride) are present in the human body and the balancing act of the electrolytes in our bodies is essential for normal function of our cells
and organs. There has to be a balance.Ionized calcium this test if you have signs of kidney or parathyroid disease. The test may also be done to monitor progress
and treatment of these diseases.
Page 7 of 12
Patient Name : Mr ALOK AHIRWAR
DOB/Age/Gender : 23 Y/Male Bill Date : Jul 05, 2023, 01:29 PM
Patient ID / UHID : 4635424/RCL1934653 Sample Collected : Jul 06, 2023, 09:22 AM
Referred By : Dr. Sample Received : Jul 06, 2023, 11:12 AM
Sample Type : Serum Report Date : Jul 06, 2023, 12:28 PM
Barcode No : BT763226 Report Status : Final Report
BIOCHEMISTRY REPORT
Fit India Full Body Checkup
Lipid Profile
TOTAL CHOLESTEROL 154 mg/dL Desirable : <200
Method : Enzymatic - Cholesterol Oxidase Borderline : 200-239
High : >240
TRIGLYCERIDES 90.2 mg/dL Normal : <150
Method : Colorimetric - Lip/Glycerol Kinase Borderline : 150-199
High : 200-499
Very high : >500
HDL CHOLESTEROL 41.4 mg/dL No Risk >55
Method : Enzymatic colorimetric Moderate risk 35-55
High risk <35.0
NON HDL CHOLESTEROL 112.6 mg/dL <130
Method : Calculated
LDL CHOLESTEROL 94.56 mg/dL Optimal <100
Method : Calculated Near optimal/above optimal
100-129 Borderline high
130-159
High 160-189
Very high =190
V.L.D.L CHOLESTEROL 18.04 mg/dL < 30
Method : Calculated
CHOL/HDL Ratio 3.72 - 3.5 - 5.0
Method : Calculated
HDL/ LDL RATIO 0.44 - Desirable : 0.5 - 3.0
Method : Calculated
Borderline : 3.1 - 6.0
Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation.
NCEP recommends of 3 different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in
single assays.
TOTAL LDL N O N H D L
N A T I O N A L L I P I D A S S O C I A T I O N CHOLESTEROL TRIGLYCERIDE
CHOLESTEROL in C H O L E S T E R O L i n
RECOMMENDATIONS (NLA-2014) in mg/dL
in mg/dL mg/dL mg/dL
Optimal <200 <150 <100 <130
Above Optimal 100-129 130 - 159
Borderline High 200-239 150-199 130-159 160 - 189
High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220
Page 8 of 12
Patient Name : Mr ALOK AHIRWAR
DOB/Age/Gender : 23 Y/Male Bill Date : Jul 05, 2023, 01:29 PM
Patient ID / UHID : 4635424/RCL1934653 Sample Collected : Jul 06, 2023, 09:22 AM
Referred By : Dr. Sample Received : Jul 06, 2023, 11:12 AM
Sample Type : Serum Report Date : Jul 06, 2023, 12:28 PM
Barcode No : BT763226 Report Status : Final Report
Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.
Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.
Risk Group Treatment Goals Consider Drug Therapy
LDL-C (mg/dl) Non-HDL (mg/dl) LDL-C (mg/dl) Non-HDL (mg/dl)
Extreme Risk Group Category A <50 (Optional goal <OR = 30) <80 (Optional goal <OR = 60) >OR = 50 >OR = 80
Extreme Risk Group Category B >OR = 30 >OR = 60 > 30 > 60
Very High Risk <50 <80 >OR = 50 >OR = 80
High Risk <70 <100 >OR = 70 >OR = 100
Moderate Risk <100 <130 >OR = 100 >OR = 130
Low Risk <100 <130 >OR = 130* >OR = 160
References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of
India. Current Vascular Pharmacology,2022,20,134-155.
Page 9 of 12
Patient Name : Mr ALOK AHIRWAR
DOB/Age/Gender : 23 Y/Male Bill Date : Jul 05, 2023, 01:29 PM
Patient ID / UHID : 4635424/RCL1934653 Sample Collected : Jul 06, 2023, 09:22 AM
Referred By : Dr. Sample Received : Jul 06, 2023, 11:12 AM
Sample Type : Serum Report Date : Jul 06, 2023, 02:03 PM
Barcode No : BT763226 Report Status : Final Report
BIOCHEMISTRY REPORT
Fit India Full Body Checkup
Iron Studies
IRON 65.3 µg/dL 33 - 193
Method : FerroZine
TIBC,(Total Iron Binding Capacity) 364.9 µg/dL 158 - 538
Method : Method :Spectrophotometric Assay
UIBC 299.6 µg/dL 125 - 345
Method : FerroZine
TRANSFERRIN SATURATION 17.9 % 15 - 50
Method : Method :Derived from IRON and TIBC values
Interpretation:
Increased levels due to iron ingestion or ineffective erythropoiesis.Decreased levels due to infection, inflammation, malignancy, menstruation and
Fe deficiency.Needs to be taken into consideration with TIBC. Transferrin Saturation:- Low level Transferrin Saturation can indicate iron
deficiency, erythropoiesis, infection, or inflammation. High level Transferrin Saturation can indicate recent ingestion of dietary iron,ineffective
erythropoiesis,haemochromatosis or liver disease.High TIBC, UIBC, or transferrin usually indicates iron deficiency, but they are also increased in
pregnancy and with the use of oral contraceptives. Low TIBC, UIBC, or transferrin may occur if someone has:Hemochromatosis, Certain types of
anemia due to accumulated iron,Malnutrition,kidney disease that causes a loss of protein in urine.
Page 10 of 12
Patient Name : Mr ALOK AHIRWAR
DOB/Age/Gender : 23 Y/Male Bill Date : Jul 05, 2023, 01:29 PM
Patient ID / UHID : 4635424/RCL1934653 Sample Collected : Jul 06, 2023, 09:22 AM
Referred By : Dr. Sample Received : Jul 06, 2023, 11:12 AM
Sample Type : Serum Report Date : Jul 06, 2023, 01:41 PM
Barcode No : BT763226 Report Status : Final Report
BIOCHEMISTRY REPORT
Fit India Full Body Checkup
Thyroid Profile Total
TRIIODOTHYRONINE ( T3 ) 1.1 ng/mL 0.71 - 2.01
Method : ECLIA
TOTAL THYROXINE ( T4 ) 10.6 µg/dL 5.1 - 14.1
Method : ECLIA
THYROID STIMULATING HORMONE (Ultrasensitive) 1.9 µIU/mL 0.27 - 4.20
Method : ECLIA
Interpretation:
Pregnancy Reference ranges TSH
1 st Trimester 0.1 - 2.5
2 ed Trimester 0.2 - 3.0
3 rd Trimester 0.3 - 3.0
Primary malfunction of the thyroid gland may result in excessive (hyper) or below normal (hypo) release of T3 or T4. In addition as TSH directly
affects thyroid function, malfunction of the pituitary or the hypo - thalamus influences the thyroid gland activity. Disease in any portion of the
thyroid-pitutary-hypothala- mus system may influence the levels of T3 and T4 in the blood. In primary hypothyroidism, TSH levels are
significantly elevated, while in secondary and tertiary hypothyroidism, TSH levels may be low. In addition, in the Euthyroid Sick Syndrome,
multiple alterations in serum thyroid function test findings have been recognized in patients with a wide variety of non-thyroidal illnesses (NTI)
without evidence of preexisting thyroid or hypothalami c-pitutary diseases. Thyroid Binding Globulin (TBG) concentrations remain relatively
constant in healthy individuals. However, pregnancy, excess estrogen's, androgen's, antibiotic steroids and glucocorticoids are known to alter
TBG levels and may cause false thyroid values for Total T3 and T4 tests.
TSH T4 T3 INTERPRETATION
High Normal Normal Mild (subclinical) hypothyroidism
Low or
High Low Hypothyroidism
normal
Low Normal Normal Mild (subclinical) hyperthyroidism
High or High or
Low Hyperthyroidism
normal normal
Low or Low or
Low Nonthyroidal illness; pituitary (secondary) hypothyroidism
normal normal
Thyroid hormone resistance syndrome (a mutation in the thyroid hormone receptor decreases thyroid
Normal High High
hormone function)
Page 11 of 12
Patient Name : Mr ALOK AHIRWAR
DOB/Age/Gender : 23 Y/Male Bill Date : Jul 05, 2023, 01:29 PM
Patient ID / UHID : 4635424/RCL1934653 Sample Collected : Jul 06, 2023, 09:22 AM
Referred By : Dr. Sample Received : Jul 06, 2023, 11:12 AM
Sample Type : Spot Urine Report Date : Jul 06, 2023, 03:25 PM
Barcode No : CI411611 Report Status : Final Report
Page 12 of 12
Terms and Conditions of Reporting
1. The presented findings in the Reports are intended solely for informational and interpretational purposes by the
referring physician or other qualified medical professionals possessing a comprehensive understanding of
reporting units, reference ranges, and technological limitations. The laboratory shall not be held liable for any
interpretation or misinterpretation of the results, nor for any consequential or incidental damages arising from
such interpretation.
2. It is to be presumed that the tests performed pertain to the specimen/sample attributed to the Customer's name
or identification. It is presumed that the verification particulars have been cleared out by the customer or his/her
representation at the point of generation of said specimen / sample. It is hereby clarified that the reports
furnished are restricted solely to the given specimen only.
3. It is to be noted that variations in results may occur between different laboratories and over time, even for the
same parameter for the same Customer. The assays are performed and conducted in accordance with standard
procedures, and the reported outcomes are contingent on the specific individual assay methods and equipment(s)
used, as well as the quality of the received specimen.
4. This report shall not be deemed valid or admissible for any medico-legal purposes.
5. The Customers assume full responsibility for apprising the Company of any factors that may impact the test
finding. These factors, among others, includes dietary intake, alcohol, or medication / drug(s) consumption, or
fasting. This list of factors is only representative and not exhaustive.
Name Patient ID Gender Age
fa lse
Health Advisory
Normal (N) Low (L) Borderline (BL) High (H)
Liver Profile
One of the main functions of your liver is to make proteins that are secreted in your blood. It also makes enzymes
which convert food into energy, and processes old muscles and cells. When your liver is damaged, enzymes leak
into your blood and appear in the blood test
Enzymes
Enzymes found in your liver are responsible for various processes that maintain body functions. These enzymes are leaked into
your blood when your liver suffers damage.
NORMAL HIGH
< 40 > 40
You: 79.2
Enzymes
Enzymes found in your liver are responsible for various processes that maintain body functions. These enzymes are leaked into
your blood when your liver suffers damage.
fa lse
NORMAL HIGH
< 41 > 41
You: 125
It showcases problems such as viral hepatitis, diabetes, congestive heart failure, liver damage, bile duct
(small tubes that pass bile -- fluid made by liver helpful for digestion -- outside liver) problems etc.
+ +
SMART HEALTH REPORT
RT
MC-5280
+
Experience With Accurate Reports With Quick Results